Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan 15;9(1):194.
doi: 10.1038/s41467-017-02632-8.

Phosphorylation-induced conformation of β2-adrenoceptor related to arrestin recruitment revealed by NMR

Affiliations

Phosphorylation-induced conformation of β2-adrenoceptor related to arrestin recruitment revealed by NMR

Yutaro Shiraishi et al. Nat Commun. .

Abstract

The C-terminal region of G-protein-coupled receptors (GPCRs), stimulated by agonist binding, is phosphorylated by GPCR kinases, and the phosphorylated GPCRs bind to arrestin, leading to the cellular responses. To understand the mechanism underlying the formation of the phosphorylated GPCR-arrestin complex, we performed NMR analyses of the phosphorylated β2-adrenoceptor (β2AR) and the phosphorylated β2AR-β-arrestin 1 complex, in the lipid bilayers of nanodisc. Here we show that the phosphorylated C-terminal region adheres to either the intracellular side of the transmembrane region or lipids, and that the phosphorylation of the C-terminal region allosterically alters the conformation around M2155.54 and M2796.41, located on transemembrane helices 5 and 6, respectively. In addition, we found that the conformation induced by the phosphorylation is similar to that corresponding to the β-arrestin-bound state. The phosphorylation-induced structures revealed in this study propose a conserved structural motif of GPCRs that enables β-arrestin to recognize dozens of GPCRs.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interests.

Figures

Fig. 1
Fig. 1
Distribution of the NMR probes on the structure of β2AR. The crystal structure of β2AR (PDB ID: 3SN6) is shown as a ribbon model. The N-terminal region, intracellular loop 3, and the C-terminal region, which are either substituted with T4 lysozyme, not observed, or truncated, are shown with dotted lines. The methionine residues observed for the analysis of the conformation of the TM region are shown as sticks. M822.53, M2155.54, and M2796.41, with resonances that reportedly exhibit remarkable chemical shift change upon activation, are shown as red sticks. The C-terminal region, which was segmentally labeled for the NMR observation, is shown by a red dotted line. The putative phosphorylated residues in the C-terminal region are shown. The structural model was prepared with Cuemol (http://www.cuemol.org/)
Fig. 2
Fig. 2
NMR spectra of the C-terminal region of the segmentally labeled β2AR. a Schematic diagram of the preparation of segmentally labeled β2AR. b Overlay of the 1H-15N HSQC spectra of the unphosphorylated (black) and phosphorylated (red) {Cterm- [2H, 13C, 15N]} β2AR in rHDLs. Resonances that were not observed in the phosphorylated β2AR are indicated with boxes, and resonances that exhibited different chemical shifts between the unphosphorylated and phosphorylated spectra are indicated with arrows. c Overlay of the 1H-13C HMQC spectra of {Cterm- [2H, Thrγ2-, Ileδ1-[13C,1H]} β2AR in rHDLs. d 1H and 13C linewidths of the T360 methyl signals of the unphosphorylated (gray bars) and phosphorylated (red bars) β2AR in rHDL. The linewidths were calculated by fitting the Lorentzian function to the signals using Topspin 3.1. The error bars indicate the standard errors of the fit
Fig. 3
Fig. 3
Conformation of the TM region of phosphorylated β2AR. Overlay of the 1H-13C HMQC spectra of [2H-9AA, αβγ-2H, methyl-13C-Met] β2AR in rHDLs in the unphosphorylated state (black) and phosphorylated state (red). Cross-sections of the resonances from M2155.54 and M2796.41 are shown above the spectra
Fig. 4
Fig. 4
Interaction between the C-terminal region of β2AR and the membrane surface examined by the methyl-directed cross-saturation experiments. a Schematic diagram of the methyl-directed cross-saturation experiment, using segmentally-labeled β2AR. b, c Methyl-directed cross-saturation spectra of the C-terminal region of unphosphorylated β2AR (b) and phosphorylated β2AR (c). Spectra with and without irradiation are shown in the right and left panels, respectively. d Intensity reduction ratio of each resonance. Gray and red bars indicate the results in the unphosphorylated state and the phosphorylated state, respectively. The error bars represent the experimental errors, calculated from the root sum square of (noise level/signal intensity) in the two spectra, with and without irradiation
Fig. 5
Fig. 5
Conformation of the TM region of the phosphorylated β2AR bound to β-arrestin. Overlay of the 1H-13C HMQC spectra of [2H-9AA, αβγ-2H, methyl-13C-Met] β2AR in rHDLs in the unphosphorylated state (black), phosphorylated state (red), and β-arrestin 1-bound state (blue). The centers of the resonances from M2155.54 to M2796.41 are indicated with dots. In the phosphorylated state, the resonance from M2796.41 could not be observed
Fig. 6
Fig. 6
Role of the phosphorylation of the C-terminal region in signal transduction. In the unphosphorylated state, the C-terminal region of β2AR is unstructured. Upon phosphorylation by GRKs, the TM-proximal region of the C-terminal region of β2AR adheres to the cytoplasmic face of the TM region, and the intracellular halves of the TM helices become spatially rearranged, which preferentially activates arrestin-mediated signal transduction. The adhesion of the phosphorylated C-terminal region to the TM-region and the spatial rearrangement of the TM helices would generate the structural motif for β-arrestin binding

Similar articles

Cited by

References

    1. Whalen EJ, Rajagopal S, Lefkowitz RJ. Therapeutic potential of β-arrestin- and G protein-biased agonists. Trends Mol. Med. 2011;17:126–139. doi: 10.1016/j.molmed.2010.11.004. - DOI - PMC - PubMed
    1. Hirsch J, Schubert C, Gurevich V, Sigler P. The 2.8 Å crystal structure of visual arrestin: a model for arrestin’s regulation. Cell. 1999;97:257–269. doi: 10.1016/S0092-8674(00)80735-7. - DOI - PubMed
    1. Han M, Gurevich VV, Vishnivetskiy SA, Sigler PB, Schubert C. Crystal structure of β-arrestin at 1.9 Å: possible mechanism of receptor binding and membrane translocation. Structure. 2001;9:869–880. doi: 10.1016/S0969-2126(01)00644-X. - DOI - PubMed
    1. Sutton R, et al. Crystal structure of cone arrestin at 2.3 Å: evolution of receptor specificity. J. Mol. Biol. 2005;354:1069–1080. doi: 10.1016/j.jmb.2005.10.023. - DOI - PubMed
    1. Zhan X, Gimenez L, Gurevich V, Spiller B. Crystal structure of arrestin-3 reveals the basis of the difference in receptor binding between two non-visual subtypes. J. Mol. Biol. 2011;406:467–478. doi: 10.1016/j.jmb.2010.12.034. - DOI - PMC - PubMed

Publication types

Substances

LinkOut - more resources